Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Mefloquine
100%
Randomized Controlled Trial
100%
Artesunate
100%
Schistosomiasis
100%
Praziquantel
83%
Antimalarial Agent
58%
Chlorhexidine Gluconate
50%
Gonorrhea
50%
Neisseria gonorrhoeae
50%
Chlorhexidine
50%
Antigen
16%
Prevalence
16%
Morbidity
16%
Adverse Event
14%
Schistosoma
14%
Schistosoma haematobium
14%
Drug Administration
8%
Drug Resistance
8%
Malaria
8%
Noninferiority Trial
8%
Schistosoma Mansoni
8%
Reinfection
8%
Adverse Effect
6%
Immunology and Microbiology
Visceral Leishmaniasis
100%
Human immunodeficiency virus
100%
Leishmaniasis
63%
Leishmania
54%
Schistosomiasis
50%
Arm
50%
Mefloquine
50%
Parasitemia
50%
Praziquantel
33%
Antigen
19%
Prevalence
16%
Morbidity
16%
CD4 Lymphocyte Count
14%
Polymerase Chain Reaction
9%
Schistosoma haematobium
8%
Malaria
8%
Reverse Transcription Polymerase Chain Reaction
8%
Schistosoma Mansoni
8%
Schistosoma
8%
Drug Resistance
8%
Medicine and Dentistry
Arm
50%
Randomized Controlled Trial
50%
Schistosomiasis
50%
Mefloquine
50%
Artesunate
50%
Praziquantel
33%
Treatment Response
16%
Antigen
16%
Prevalence
16%
Morbidity
16%
School-Aged Child
8%
Oral
8%
Reinfection
8%
Patient Monitoring
8%
Antimalarial
8%
Informed Consent
8%
Single Drug Dose
8%
Drug Administration
8%
Noninferiority Trial
8%
Schistosoma Mansoni
8%
Schistosoma haematobium
8%
Drug Resistance
8%
Malaria
8%
Schistosoma
8%
Adverse Event
8%